Close Asset Management LTD Avadel Pharmaceuticals PLC Transaction History

Close Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$4.06 - $10.64 $60,899 - $159,600	-15,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$1.44 - $3.29 $21,366 - $48,817	14,838 Added 9159.26%	15,000 $22,000
Q4 2018 Jan 28, 2019	SELL	$1.74 - $4.66 $25,818 - $69,145	-14,838 Reduced 98.92%	162 $7,000
Q2 2017 Nov 14, 2017	BUY	N/A	15,000	15,000 $0

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $626M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Close Asset Management LTD with notifications on news.